Praxis Precision Medicines Inc Aktie News
173,97 $
2,27 %
vorgestern
Nasdaq,
24. Oktober, 22:00 Uhr
tracken
Praxis Precision Medicines Inc Aktie News
Positiv
The Motley Fool
●
etwa 14 Stunden alt
Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision Medicine announced successful results from a phase 3 trial with its lead candidate.
Neutral
GlobeNewsWire
●
10 Tage alt
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the pricing of its underwritten public offering of 3,025,480 shares of its common ...
Neutral
Seeking Alpha
●
10 Tage alt
Praxis Precision Medicines, Inc. (NASDAQ:PRAX ) Discusses Essential3 Topline Results and Next Steps in Essential Tremor Program October 16, 2025 8:00 AM EDT Company Participants Marcio Souza - President, CEO & Director Conference Call Participants Daniel Ferry - Lifesci Advisors, LLC Ritu Baral - TD Cowen, Research Division Yasmeen Rahimi - Piper Sandler & Co., Research Division Joon Lee - Trui...
Neutral
GlobeNewsWire
●
10 Tage alt
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced a proposed public offering of its common stock and, in lieu of common stock to cer...
Positiv
Market Watch
●
10 Tage alt
Shares of Praxis Precision Medicines have hit their highest intraday level since March 2022.
Positiv
Invezz
●
10 Tage alt
Praxis Precision Medicines (NASDAQ: PRAX stock) saw a skyrocketing 235% rally on Thursday after announcing positive topline results from two pivotal Phase 3 studies of ulixacaltamide for essential tremor, a common movement disorder.
Positiv
Investors Business Daily
●
10 Tage alt
Shares of Praxis Precision Medicines skyrocketed more than 200% Thursday on "groundbreaking" test results for an essential tremor treatment.
Positiv
Reuters
●
10 Tage alt
Praxis Precision Medicines said on Thursday its experimental drug for movement disorder helped improve daily functioning in patients in two late-stage trials.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
